# US 2026/0168116 A1 · Engineering of a Photoautotrophic Cell for CO2 Fixation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0168116 A1
- Document ID: US20260168116A1
- Status: Published application
- Kind: A1
- Application number: 19/112,935
- Filed: 2023-09-21
- Published: 2026-06-18
- Earliest claimed: 2022-09-21
- Assignees: Oxford University Innovation Limited
- Applicants: Oxford University Innovation Limited
- Inventors: Wei HUANG; Weiming TU
- Web page: https://patentgrep.com/patent/US20260168116A1

## CPC

- C25B 9/50: Cells or assemblies of cells comprising photoelectrodes; Assemblies of constructional parts thereof
- C12N 9/0069: {acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)}
- C12N 9/88: Lyases (4.)
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 15/74: Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12P 23/00: Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes (containing heterorings C12P17/00)
- C12Y 113/11065: Carotenoid isomerooxygenase (1.13.11.65)
- C12Y 402/01001: Carbonate dehydratase (4.2.1.1), i.e. carbonic anhydrase
- C25B 3/21: Photoelectrolysis
- C25B 3/26: of carbon dioxide
- C25B 9/19: with diaphragms
- C12N 2800/101: for bacteria
- C12R 2001/01: Bacteria or Actinomycetales {; using bacteria or Actinomycetales}
- C25B: ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR (anodic or cathodic protection C23F13/00; single-crystal growth C30B)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The invention relates to an electromicrobial system for photoautotrophic CO2 fixation, comprising: A) a recombinantly engineered bacterial cell modified for photoautotrophic CO2 fixation, wherein the bacterial cell comprises membrane-bound rhodopsin molecules and components for a CO2 fixation pathway; and B) an electron source for donation of electrons into the electron transport chain; and related methods, uses and products.

## Claims

### Claim 1

An electromicrobial system for photoautotrophic CO2 fixation, comprising:
a recombinantly-engineered bacterial cell configured for photoautotrophic CO2 fixation, wherein the recombinantly-engineered bacterial cell comprises a membrane-bound rhodopsin molecule and a CO2 fixation pathway; and
an electron source.

### Claim 2 (depends on 1)

The electromicrobial system according to claim 1, wherein the recombinantly-engineered bacterial cell comprises a recombinantly-engineered R. eutropha cell.

### Claim 3 (depends on 1)

The electromicrobial system according to claim 1, wherein the membrane-bound rhodopsin molecule comprises a proteorhodopsin (PR) or a Gloeobacter rhodopsin (GR).

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The electromicrobial system according to claim 1, wherein the recombinantly-engineered bacterial cell is configured for retinal biosynthesis.

### Claim 6 (depends on 1)

The electromicrobial system according to claim 1, wherein the recombinantly-engineered bacterial cell comprises retinal.

### Claim 7 (depends on 5)

The electromicrobial system according to claim 5, wherein:
the recombinantly-engineered bacterial cell is configured for β-carotene biosynthesis; and
the recombinantly-engineered bacterial cell expresses β-carotene 15, 15′-dioxygenase.

### Claim 8 (depends on 1)

The electromicrobial system according to claim 1, wherein the recombinantly-engineered bacterial cell comprises dxs, dxr, ispH, ispA, crtE, crtB, crtI, crtY, and/or blh.

### Claim 9 (depends on 1)

The electromicrobial system according to claim 1, wherein:
the recombinantly-engineered bacterial cell expresses 1-deoxy-D-xylulose-5-phosphate synthase, 1-deoxy-D-xylulose 5-phosphate reductoisomerase, 4-hydroxy-3-methylbut-2-enyl diphosphate reductase, farnesyl diphosphate synthase, geranylgeranyl diphosphate synthase, phytoene synthase, phytoene desaturase, lycopene cyclase, and/or β-carotene 15, 15′-dioxygenase;
the recombinantly-engineered bacterial cell expresses 1-deoxy-D-xylulose-5-phosphate synthase, 1-deoxy-D-xylulose 5-phosphate reductoisomerase, 4-hydroxy-3-methylbut-2-enyl diphosphate reductase, farnesyl diphosphate synthase, geranylgeranyl diphosphate synthase, phytoene synthase, phytoene desaturase, and/or lycopene cyclase, wherein the recombinantly-engineered bacterial cell further expresses β-carotene 15, 15′-dioxygenase;
the recombinantly-engineered bacterial cell expresses 1-deoxy-D-xylulose-5-phosphate synthase, 1-deoxy-D-xylulose 5-phosphate reductoisomerase, 4-hydroxy-3-methylbut-2-enyl diphosphate reductase, farnesyl diphosphate synthase, geranylgeranyl diphosphate synthase, phytoene synthase, phytoene desaturase, lycopene cyclase, and/or β-carotene 15, 15′-dioxygenase;
the recombinantly-engineered bacterial cell comprises: i) crtI, crtY, crtE and crtB; and ii) a gene encoding-carotene 15, 15′-dioxygenase; or
the recombinantly-engineered bacterial cell: i) is a R. eutropha cell; ii) comprises crtI and crtY; and iii) comprises functional, endogenous crtE and crtB genes.

### Claim 10 (depends on 1)

The electromicrobial system according to claim 1, wherein the recombinantly-engineered bacterial cell comprises an Erwinia uredovora (Pantoea ananatis) crtEXYIB operon.

### Claim 11 (depends on 1)

The electromicrobial system according to claim 1, wherein:
the recombinantly-engineered bacterial cell is configured for expression of β-carotene 15, 15′-dioxygenase;
the recombinantly-engineered bacterial cell is further configured to overexpress an endogenous dxr gene; and/or
the recombinantly-engineered bacterial cell comprises a recombinant dxr gene.

### Claim 12 (depends on 1)

The electromicrobial system according to claim 1, wherein the electron source comprises an electrode linked to a source of electricity and/or an electron donor molecule.

### Claim 13

(canceled)

### Claim 14 (depends on 1)

The electromicrobial system according to claim 1, wherein an electron is mediated via an electron mediator.

### Claim 15 (depends on 1)

The electromicrobial system according to claim 1, wherein the electron source comprises an electrode disposed in a dual chamber electrode system.

### Claim 16 (depends on 1)

The electromicrobial system according to claim 1, further comprising riboflavin.

### Claim 17 (depends on 1)

The electromicrobial system according to claim 1, wherein the recombinantly-engineered bacterial cell is configured for the production of an organic product.

### Claim 18

A bacterial cell configured for photoautotrophic CO2 fixation, wherein the bacterial cell comprises a rhodopsin and the components for a CO2 fixation pathway.

### Claim 19 (depends on 18)

The bacterial cell according to claim 18, wherein the bacterial cell comprises an R. eutropha cell.

### Claim 20 (depends on 18)

The bacterial cell according to claim 18, wherein the rhodopsin comprises a proteorhodopsin (PR) or a Gloeobacter rhodopsin (GR).

### Claim 21

(canceled)

### Claim 22 (depends on 18)

The bacterial cell according to claim 18, wherein the bacterial cell is configured for retinal biosynthesis.

### Claim 23

(canceled)

### Claim 24 (depends on 1)

A method of CO2 fixation and/or biosynthesizing an organic product, the method comprising:
providing the electromicrobial system according to claim 1; and
culturing the recombinantly-engineered bacterial cell in the presence of light and CO2.

### Claim at position 25

25-29. (canceled)
